An innovative and gen-next drug delivery and biosensor technology has been launched by Lemonex- a global biotherapeutics and bioengineering firm, headquartered in Seoul. With regards to the technology, the firm will be able to develop immune-oncology drugs, gene therapeutics and antibody. Lemonex’s core technologies are Pango and DegradaBall.
The company has won the 11th Innobiz Company Award, sponsored by the Ministry of....
Tags : drug delivery and biosensor technology, Lemonex, Pango, DegradaBall ,
comments (0)